Name
Session IV: Bispecifics
Date & Time
Monday, June 22, 2026, 3:40 PM - 4:40 PM
Bas Baaten, PhD Brian O'Connor, PhD Dimitris Skokos, PhD
Description

 

Chairperson: Bas Baaten, PhD, Pfizer 

3:40 PM

Whole is greater than the sum: Mechanistic evaluation of PF-08634404, Pfizer's PD1xVEGF bispecific

Brian P. O’Connor, PhD, Pfizer 

4:10 PM

Unlocking the Immune System: Advances in Novel Combination Strategies for Cancer Immunotherapy
Dimitris Skokos, PhD
, Regeneron